FDA Crisis Management: Behind-The-Scenes Of Josh Hardy's Compassionate Use
This article was originally published in The Pink Sheet Daily
Executive Summary
Chimerix's former CEO and an FDA official recount campaign for dying child’s access to experimental drug; company adversary now recommends partnership with industry rather than social media push.